The Math Shows GNOM Can Go To $17
December 16, 2024 at 07:42 AM EST
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Genomics & Biotechnology ETF (GNOM), we found that the implied analyst target price for the ETF based upon its underlying holdings is $16.86 per unit.
